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Assessment of Autonomic
Function in Cardiovascular Disease
Physiological Basis and Prognostic Implications
Marc K. Lahiri, MD, Prince J. Kannankeril, MD, Jeffrey J. Goldberger, MD, FACC
Chicago, Illinois
Certain abnormalities of autonomic function in the setting of structural cardiovascular disease have been associ-
ated with an adverse prognosis. Various markers of autonomic activity have received increased attention as
methods for identifying patients at risk for sudden death. Both the sympathetic and the parasympathetic limbs
can be characterized by tonic levels of activity, which are modulated by, and respond reflexively to, physiological
changes. Heart rate provides an index of the net effects of autonomic tone on the sinus node, and carries prog-
nostic significance. Heart rate variability, though related to heart rate, assesses modulation of autonomic control
of heart rate and carries additional prognostic information, which in some cases is more powerful than heart
rate alone. Heart rate recovery after exercise represents the changes in autonomic tone that occur immediately
after cessation of exercise. This index has also been shown to have prognostic significance. Autonomic evalua-
tion during exercise and recovery may be important prognostically, because these are high-risk periods for sud-
den death, and the autonomic changes that occur with exercise could modulate this high risk. These markers
provide related, but not redundant information about different aspects of autonomic effects on the sinus
node. (J Am Coll Cardiol 2008;51:1725–33) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.01.038o
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(umerous experimental and clinical studies have demon-
trated that certain measures of autonomic function in the
etting of structural cardiovascular disease are associated
ith an adverse prognosis. Specifically, both increased
ympathetic and decreased parasympathetic activity have
een associated with an increased risk for sudden death
nd/or susceptibility to ventricular arrhythmias. For exam-
le, there is an increased incidence of reperfusion-induced
entricular fibrillation with sympathetic stimulation in dogs
1). Conversely, parasympathetic stimulation decreases the
ncidence of ventricular fibrillation during ischemia in ex-
rcising dogs with myocardial infarctions (MIs) (2). In
umans, beta-blockers decrease the incidence of sudden
ardiac death after MI and in patients with congestive heart
ailure (3–9). This link between the autonomic nervous
ystem and sudden death has stimulated interest in the
valuation of autonomic function as a potential method for
dentifying patients at high risk for sudden death.
Although autonomic modulation of the cardiovascular
ystem is likely to be important in the pathogenesis of
udden cardiac death, it remains difficult to measure or
uantify. Although a simple relationship between a physi-
rom the Division of Cardiology, Department of Medicine, Northwestern University,
hicago, Illinois.a
Manuscript received October 10, 2007; revised manuscript received December 20,
007, accepted January 6, 2008.logical marker and autonomic “activity” would be attrac-
ive, the autonomic nervous system is extremely complex,
aking it difficult to elucidate such a simple relationship. A
ariety of markers have been proposed to reflect autonomic
activity,” including heart rate, heart rate variability, heart
ate recovery after exercise, baroreflex sensitivity, heart rate
urbulence, plasma/coronary sinus catecholamine levels,
uscle sympathetic nerve activity, and others. Because heart
ate can be measured noninvasively and inexpensively, much
ocus has been placed upon analysis of heart rate and heart
ate variability. It is therefore important to relate these
arkers to their physiological counterparts to understand
ow abnormalities in these measures may be implicated in
he pathogenesis of sudden cardiac death. In a stable
hysiological state, the sympathetic and parasympathetic
imbs can be considered to have tonic levels of activity which
enerally have antagonistic effects. Spontaneous physiolog-
cal processes, such as respiration, further modulate the
onic level of activity. Finally, tonic activity responds reflex-
vely to various “stresses,” such as changes in blood pressure
ia the baroreflex mechanism and exercise. The study of
hese physiological responses of the sinus node depend upon
ntact sinus node function.
In the present paper, we review the following methods of
utonomic assessment: heart rate (HR), heart rate variability
HRV) and heart rate recovery after exercise (HRR), with
n emphasis on the physiological basis for each marker.
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Assessment of Autonomic Function May 6, 2008:1725–33Their relationships to each other
as well as their prognostic impli-
cations will be explored.
HR
The sinus node has an intrinsic
rate of spontaneous depolariza-
tion, known as the intrinsic HR
(10). The intrinsic HR is the HR
measured in the absence of sym-
pathetic and parasympathetic in-
puts (achieved by denervation or
harmacologic blockade). In healthy human subjects, this is
pproximately 100 beats/min and is age and gender depen-
ent (10); endurance exercise-trained individuals may have
lower intrinsic HR (11). It is important to note that
onautonomic contributions to changes in HR exist: hyp-
xia, exercise, and temperature all can affect the intrinsic
R (12,13). Sympathetic and parasympathetic effects on
he intrinsic HR predominantly determine the actual HR.
arasympathetic activation slows the HR via acetylcholine
elease from efferent vagal nerve discharge. In contrast,
ympathetic activation accelerates the HR via circulating
pinephrine, neural release of norepinephrine, or both (14).
n a given stable physiological state, the sympathetic and
arasympathetic inputs can be considered to have a tonic
evel of activity which determines the HR for that state. The
nfluences of the sympathetic and parasympathetic nervous
ystems on HR have been proposed to be defined by the
ollowing formula: HR  m  n  HR0; where m is the
ympathetic influence (1), n is the parasympathetic influ-
nce (1), and HR0 is the intrinsic HR (15). Thus, HR is
etermined by the intrinsic rate, and some measure of the
onic sympathetic and parasympathetic effects on the sinus
ode. Additionally, there are interactions between the
ympathetic and parasympathetic limbs that determine their
espective effects on HR. The effect of one limb is enhanced
y increased activity of its counterpart, a phenomenon
ermed accentuated antagonism (16,17). In the absence of
ympathetic activity, a given degree of parasympathetic
timulation will cause a given change in HR (from 100 to 90
eats/min, for example). The presence of sympathetic ac-
ivity, though increasing HR (to 120 beats/min), allows the
ame degree of parasympathetic stimulation to cause a
reater change in HR (from 120 to 105 beats/min).
Based on the model proposed by Rosenblueth and Sime-
ne (15), HR seems to be a simple measure which can
rovide an index of the net effects of sympathetic and
arasympathetic inputs to the sinus node. The HR consis-
ently responds in an expected direction based on the
nderlying physiological state. That is, sympathetic stimu-
ation consistently raises HR no matter what the stimulus is.
arasympathetic blockade raises HR, whereas parasympa-
hetic stimulation lowers HR. In experimental settings, the
Abbreviations
and Acronyms
HF  high frequency
HR  heart rate
HRR  heart rate recovery
HRV  heart rate variability
LF  low frequency
SDNN  standard deviation
of normal R-R intervals
VLF  very low frequency-R interval, reciprocally related to the HR, is directly telated to vagal nerve activity (18). In a study of normal
ubjects exposed to a wide range of autonomic conditions,
ncluding upright tilt, exercise, epinephrine infusion, iso-
roterenol infusion, phenylephrine infusion, and parasym-
athetic blockade with atropine, HR responded in the
xpected direction for all subjects under all conditions tested
19). In the same study, none of the time and frequency
omain measurements of HRV responded as consistently as
he HR.
Although HR can be a powerful tool in the assessment of
utonomic tone, it has obvious limitations. It provides a
tatic index of the net effects of autonomic input to the sinus
ode, but no direct information regarding either sympa-
hetic or parasympathetic input individually. For example,
n HR of 110 beats/min demonstrates a net predominance
f sympathetic effect on the sinus node. However, sympa-
hetic stimulation, parasympathetic withdrawal, or various
ombinations of both may achieve this HR. Heart rate alone
rovides information regarding relative effects of autonomic
one in a given state, but not modulation or reflex activity.
The prognostic value of HR has been assessed in several
arge studies. High resting HR has been associated with
ncreased all-cause mortality, death from cardiovascular
isease, and particularly sudden cardiac death (20–23) in
opulation-based studies. Jouven et al. (23) recently re-
orted that a resting HR75 beats/min in patients without
linical evidence of coronary disease conferred a nearly
-fold risk for sudden cardiac death compared with those
ho had HR 60 beats/min over a 23-year follow-up
eriod (23). Average HR on 24-h ambulatory electrocar-
iograms correlates with the incidence of new coronary
vents in patients with heart disease (24). In patients
ospitalized with MI, high admission and discharge HRs
re associated with an increase in both short- and long-term
ortality (25–27). Comparison of trials of beta-blocker
herapy after MI relates the reduction in resting HR to
he percentage reduction in mortality in these trials (28).
hus, the simple measure of HR provides a global index
f autonomic tone that has important prognostic signif-
cance. Despite the important role of HR and HR
eduction in the prognosis of patients with cardiovascular
isease, it is not widely recognized or used as a factor for
isk assessment (29).
RV
he oscillation in the intervals between consecutive heart
eats has been described by several names, but heart rate
ariability has become the conventionally accepted term
30). Several methods of measuring the variation in HR
ave been developed, each of which falls under the broader
escription of being either “time domain” or “frequency
omain” analyses. It should be noted that no one method
as been identified as “superior” to the others, because no
old standard for HRV measurement exists; rather, these
echniques may be considered to be complementary to each
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May 6, 2008:1725–33 Assessment of Autonomic Functionther. Time domain measures of HRV are assessed with
alculations based on statistical operations on R-R intervals
31). Commonly used measures include standard deviation
f normal R-R intervals (SDNN), the root mean square of
uccessive R-R interval differences (MSSD), and the per-
entage of normal R-R intervals that differ by 50 ms
pNN50). Although all these are measures of HRV, they are
ot interchangeable, nor do they necessarily reflect similar
hysiology. For example, the SDNN is related to the total
ower (variance) whereas both MSSD and pNN50 detect
igh frequency oscillations. However, it should be noted
hat all HRV is substantially suppressed by parasympathetic
lockade.
Frequency domain measures use spectral analysis of a
equence of R-R intervals and provide information on how
ower (variance) is distributed as a function of frequency.
hort-term recordings (2 to 5 min) yield up to 3 peaks in
ery low (0.003 to 0.04 Hz; VLF), low (0.04 to 0.15 Hz;
F), and high (0.15 to 0.4 Hz; HF) frequency ranges.
ong-term (24-h) recordings allow measurement of a
ourth, ultralow (0.003 Hz; ULF) frequency range. It is
mportant to note that HRV measurements made from
ong-term recordings during which circadian rhythms are
resent and patient activity is not controlled provide differ-
nt physiological information than HRV measurements
ade from short-term recordings during which conditions
re typically controlled or stable. The LF and HF powers
re often reported in normalized (relative or fractional)
nits, which represent the relative value of each power in
roportion to the total power (usually minus the VLF
omponent). This is done to minimize the effect of changes
n total power on the value of HF and LF components. As
ill be described subsequently, the HF component is
hought to reflect the modulation of vagus nerve discharge
aused by respiration, whereas the LF and VLF components
epresent the variation in R-R interval caused by more
radual interplay between sympathetic and parasympathetic
ctivities. The physiological basis for the ULF component is
ot well defined (29).
Newer nonlinear analysis techniques have been applied to
urther characterize HRV. Although the aforementioned
raditional HRV methods characterize variability in R-R
ntervals within certain time scales or frequencies, nonlinear
nalyses describe the structure of the variability indepen-
ently of the scale studied. This concept relates to the
bservation that whereas different fluctuation patterns are
bserved within specific time periods or frequencies (using
raditional techniques), other self-similar fluctuation pat-
erns may also be elicited from a broad range of data scales.
uch methods gather information not detected by tradi-
ional techniques. For example, although a short-term
ecording of a patient’s normal R-R intervals will have an
dentical SD as the same set of R-R intervals that are
andomly shuffled, the underlying structure of these two sets
f R-R intervals are completely different (32). It is this cnderlying pattern that nonlinear analysis methods attempt
o describe.
Although the interplay between the sympathetic and
arasympathetic inputs is different for each of the HF, LF,
nd VLF components of HRV, it appears that parasympa-
hetic effects play a very important role in all of them.
espiratory sinus arrhythmia is a reflection of parasympa-
hetic effects on the sinus node (33), and the HF component
f HRV coincides with the respiratory frequency. Parasym-
athetic blockade with atropine results in 90% decrease in
he power contained in this frequency (33), whereas beta-
drenergic blockade with propranolol does not alter the HF
ower significantly (34). Atropine also reduces HRV in the
F (34–36), which could be ascribed to blockade of vagally
ediated fluctuations in HR provoked by sympathetically
ediated changes in arterial pressure (37). Furthermore,
arasympathetic blockade has also been shown to reduce the
LF component of HRV by 92% (38). The mechanism
ehind the vagal influence on the VLF component is not
lear; fluctuations in the renin-angiotensin-aldosterone sys-
em as well as variations in thermoregulatory mechanisms
ave been speculated.
One reason for the association of each limb of the
utonomic nervous system with a different frequency range
tems from the fact that the timing of the HR response to
utonomic nerve activity is not identical for each limb.
lthough a burst of vagal nerve activity has a maximal effect
t 0.6 s with a return to baseline within 1 s, a sympathetic
urst has no effect for 1 s, a maximal effect at 4 s, and
return to baseline within 20 s (39). Both cardiac and
eripheral sympathetic responses have a similar time delay
40). The short delay of the vagal cardiac responses allows
he parasympathetic nervous system to modulate HR at all
requencies between 0 and 0.5 Hz, although the sympa-
hetic system has significant gain only below 0.15 Hz (41).
uscle sympathetic nerve activity has been shown to
uctuate every 10 s (42), a period long enough for vascular
mooth muscle and sinus node effectors to respond to
eleased norepinephrine and modulate blood pressure and
R (43). This period corresponds to the LF range observed
n HRV. The absolute and normalized LF powers have
herefore been used as an index of sympathetic modulation
f the heart rate, and the ratio of absolute LF to HF power
as been used as an index of “sympathovagal balance”
40,44), although this term is poorly defined (19,37).
pright tilt, which increases sympathetic tone predomi-
antly due to an increase in direct neural stimulation (33),
onsistently increases LF and LF/HF power and decreases
ime domain measures of HRV (45); beta-blockade blunts
hese changes (40).
Although the idea of a simple relationship between
omponents of HRV and sympathetic or parasympathetic
one is attractive, several studies indicate that the relation-
hip is more complex. Despite the fact that in certain
ettings there appears to be a direct relationship between
ertain measures of HRV and either sympathetic or para-
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Assessment of Autonomic Function May 6, 2008:1725–33ympathetic activity, there are many examples where these
elationships degenerate. For example, different modes of
eta-adrenergic activation (exercise, catecholamine infusion,
nd upright tilt) result in divergent changes in frequency
omain indices which have been reported to reflect sympa-
hetic activity (34). Partial parasympathetic blockade and
aroreflex-mediated sympathetic withdrawal to similar de-
rees (as determined by HR) result in diminished HF
ower, but to different degrees (46). A 10-fold difference in
F power demonstrated at different respiratory rates be-
ween 0.4 and 0.1 Hz (24 to 6 breaths/min) despite similar
R again shows that HF power can vary greatly despite
imilar levels of parasympathetic effect (47) and underscores
he role of modulation of HR as the determinant of HRV.
aroreflex-mediated increased parasympathetic activity
ith phenylephrine may actually decrease HF power and
ime domain measures at high levels of stimulation (48)
wing to saturation of the HRV response (49). The complex
elationship between HRV and parasympathetic effect was
emonstrated in normal subjects after beta-blockade (50).
sing baroreflex-mediated increases and decreases in para-
ympathetic tone, it was shown that HRV initially increases
ith increasing parasympathetic effect until it reaches a
lateau. Beyond this, further increases in parasympathetic
ffect actually decrease HRV. Of note, marked interindi-
idual variability in this relationship was noted. Therefore,
RV should be considered to be a technique that
haracterizes the modulation of autonomic tone. Al-
hough there is some relationship between the modula-
ion of autonomic tone and its tonic effect, this relation-
hip may be quite complex and individualized. It has also
een shown that genetic factors may be important deter-
inants of HRV (51,52). It is therefore difficult to relate
pecific HRV measurements to either sympathetic or
arasympathetic tone.
The relationship between HR and HRV has been well
tudied. In an animal study, vagal nerve stimulation de-
reased HR, with a clear correlation between stimulation
ntensity and change in R-R interval (53). Vagal stimulation
lso increased time and frequency domain measurements of
RV, but with little to no correlation between HRV
easures and stimulus intensity. Sympathetic stimulation
ncreased HR, with an inverse correlation between R-R
nterval and stimulus intensity, but there was no significant
ffect on time or frequency domain measures of HRV.
hus, in this animal model, HR and HRV responded
ifferently to parasympathetic and sympathetic stimulation.
everal studies in humans have examined this relationship as
ell. In one study of healthy subjects, a moderate correlation
etween mean HR and time domain measures of HRV on
4-h ambulatory electrocardiograms was demonstrated (54).
owever, several other investigations in patients with cor-
nary artery disease or heart failure found no significant
orrelation between mean, minimum, or maximum HR and
ime or frequency domain measures of HRV (55–57). gThe prognostic significance of HRV in cardiovascular
isease is widely reported. Decreased HRV has been asso-
iated with increased mortality in patients after MI, with
eart failure, and with ischemic and idiopathic cardiomy-
pathy (58–65). Large epidemiologic studies have also
inked an increased risk of coronary heart disease, death, and
ardiac mortality with decreased HRV in general popula-
ions (66–68). Although it is clear that low HRV has a
egative prognostic impact, it is important to point out that
ausality and mechanisms have not been established. Ani-
al studies have shown that interventions which improve
he HRV profile do not necessarily decrease risk for sudden
eath. In a study of post-infarction dogs at high risk for
entricular fibrillation during exercise and ischemia, the
ogs were treated with intravenous scopolamine, which at
ow doses has a parasympathomimetic effect. Although
copolamine increased the time and frequency domain
easures of HRV, there was no decreased risk of ventricular
brillation (69). In contrast, exercise training in a similar
anine model increased HRV and conferred protection from
udden death (70). The pathophysiological link between
educed HRV and increased mortality is unclear. In the
ecent DINAMIT (Defibrillator in Acute Myocardial In-
arction Trial) (71), patients who had a recent MI, reduced
jection fraction, and impaired autonomic tone (as indicated
y decreased HRV or high resting HR) did not have a
urvival benefit when treated with an implanted defibrilla-
or, even though earlier studies have correlated early de-
reases in HRV within the first 48 h of MI with worse
utcomes (72). On the other hand, cardiac resynchroniza-
ion therapy with biventricular pacemakers has recently been
hown to improve survival in a select group of patients with
YHA functional class III or IV heart failure and cardiac
yssynchrony (73). Although the exact mechanism of the
enefit has not been identified, cardiac resynchronization
herapy has been demonstrated to increase HRV (74);
lterations in the autonomic modulation of the heart could
lay a role in the improved survival. This connection was
urther strengthened by a recent study of 113 patients with
YHA functional class III or IV heart failure, which found
hat those with improved time domain measures of HRV
by the SDNN method) 4 weeks after initiation of cardiac
esynchronization therapy had better outcomes compared
ith those with less pronounced responses (75). Thus,
RV appears to be an important marker of mortality risk
or sudden cardiac death, and some (but not all) interven-
ions that improve HRV may also reduce the risk of sudden
ardiac death. A causal relationship between low HRV and
eath has not been established.
Comparisons between the prognostic significance of HR
ersus HRV have been assessed in a few large studies. In a
tudy of 808 patients after MI, HRV was an independent
nd better predictor of mortality compared with mean HR
58). A subsequent study, performed in the thrombolytic
ra, found that mean HR on 24-h recordings was nearly as
ood a predictor of all-cause mortality, as well as cardiac and
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May 6, 2008:1725–33 Assessment of Autonomic Functionudden death, as HRV (76). In a study of 6,693 patients
ith 24-h Holter recordings, the adjusted relative risk for
udden death over a 2-year period was similar for low HRV
nd high minimum HR, but mean HR had no relation to
udden death (77).
Heart rate variability is a complex measure of modulation
f HR that incorporates sympathetic effects, parasympa-
hetic effects, and their interaction. Heart rate variability
ppears to be related to HR under certain conditions. It is
n important marker of adverse prognosis in patients with
ardiac disease and in normal populations. It is important to
elineate the supplemental prognostic information con-
ained in HRV over HR. Further understanding of the
athophysiological relationship of low HRV to mortality
ill be useful in developing strategies that could increase
RV and may improve survival.
R Recovery
xercise is associated with increased sympathetic and de-
reased parasympathetic activity (78–80). The period of
ecovery after exercise is accompanied by further dynamic
hanges in autonomic tone which are clinically characterized
y the gradual return of HR to its previous resting level.
his period of HRR results from a combination of sympa-
hetic withdrawal and parasympathetic reactivation. Earlier
tudies have provided conflicting data as to which of these 2
rocesses plays the greater role in the physiology of early
RR. Savin et al. (81) studied the HRR of 6 men in whom
elective autonomic blockade was administered on different
ays before the initiation of exercise. They interpreted their
ndings as suggesting that “sympathetic withdrawal con-
ributes more to HRR soon after peak exercise cessation,
ith parasympathetic activation playing a greater role later
n recovery at lower rates.” In contrast, Imai et al. (82)
eported that “the initial HRR within 30 seconds is medi-
ted primarily by vagal reactivation.” In that study, the
nvestigators evaluated groups of young (age 20 years),
rained athletes, older (age 55 years) subjects with conges-
ive heart failure, and age-matched sedentary controls.
tropine was administered before exercise, and subjects
xercised submaximally to anaerobic threshold. Heart rate
ecovery was evaluated only up to 2 min. More recent data
lso have demonstrated that parasympathetic activation
lays a substantial role early in HRR after high-intensity
xercise in normal subjects. Kannankeril et al. (83) analyzed
R in 10 healthy individuals during peak exercise and
ecovery under normal physiological conditions as well as
uring selective parasympathetic blockade with atropine.
hese data demonstrated that even during peak high-
ntensity exercise, the parasympathetic system has a small
ut significant effect on HR, indicating that parasympa-
hetic withdrawal is not complete under such conditions.
pon cessation of exercise, augmentation of parasympa-
hetic effects on HR occurred rapidly within the first
inute. The intensity of parasympathetic reactivation dteadily increased further until 4 min into recovery, after
hich time parasympathetic effects on HR remained rela-
ively constant. The question of how much sympathetic
ithdrawal contributes to HRR after exercise was addressed
n a recent study by Sundaram et al. (84). In that study,
RR after submaximal exercise was analyzed in 28 healthy
ubjects during normal physiological condition, as well as
uring selective beta-adrenergic blockade with propranolol,
elective parasympathetic blockade with atropine, or double
lockade with both agents. In the first minute of recovery,
here was no difference in HRR between the conditions of
arasympathetic blockade and double blockade, suggesting
hat beta-adrenergic withdrawal is not a significant factor in
RR within the first minute. Interestingly, there was a
ignificant component of HRR seen in the group undergo-
ng double blockade. This implies that there is a non–beta-
drenergic, nonparasympathetic component of HRR. Pos-
ible mechanisms could include changes in alpha-adrenergic
one, atrial stretch, or temperature changes. Collectively,
hese data suggest that early HRR after exercise is complex
ut predominantly due to parasympathetic reactivation,
ith sympathetic and nonautonomic components probably
laying lesser roles.
There are compelling data to support the prognostic
ignificance of HRR following exercise. Recently, Jouven
t al. (23) reported that an HRR 25 beats/min after the
rst minute of recovery conferred a relative risk of 2.2 for
udden cardiac death compared with the highest-percentile
RR group (40 beats/min) (23). In an earlier study, Cole
t al. (85) defined an abnormal HRR as a decrease in HR
rom peak exercise to 1 min into recovery of 12 beats/min or
ess. In a cohort of 2,428 subjects without a prior history of
eart failure, coronary revascularization, coronary angiogra-
hy, or exercise testing, there was a 4-fold risk of death in
hose with abnormal HRR. After adjustment for age,
ender, medications, perfusion defects on thallium scintig-
aphy, standard cardiac risk factors, resting HR, change in
R with exercise, and workload achieved, there was still a
-fold risk of death in those with abnormal HRR. Though
hat study specifically investigated HRR after peak
ymptom-limited exercise, there are also data to suggest that
mpaired HRR after submaximal exercise has prognostic
alue as well. Cole et al. (86) defined abnormal HRR after
ubmaximal exercise as a change of 42 beats/min from
eak HR to that measured 2 min into recovery. In that
tudy, patients with abnormal HRR after submaximal ex-
rcise incurred a relative risk of death of 2.58 during 12
ears of follow-up. This increased risk remained significant
fter adjustment for standard risk factors, fitness, and resting
nd exercise HR. These data imply that HRR has prognos-
ic implications under a broad range of exercise conditions.
urthermore, this prognostic value has been shown to
epresent risk independent of that based on the Duke
readmill Score, suggesting that additive benefit may be
erived from incorporating such measurements into stan-
ard treadmill test reporting (87). Interestingly, there is
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Assessment of Autonomic Function May 6, 2008:1725–33vidence that impaired HRR after exercise may be a
odifiable risk factor. This was demonstrated in a recent
tudy (88) that retrospectively studied HRR in 55 patients
articipating in phase II cardiac rehabilitation, an activity
hat has been shown to improve survival in patients follow-
ng MI (89,90). The HRR was analyzed in 55 patients who
ad symptom-limited treadmill tests both before and after
ompleting phase II cardiac rehabilitation. After completing
ardiac rehabilitation, these patients had significantly lower
esting HR compared with pre-rehabilitation measurements
65 beats/min vs. 69 beats/min; p  0.01) and had a 26%
mprovement in their HRR during the first minute after
xercise (15.4 beats/min pre-rehabilitation vs. 19.4 beats/
in post-rehabilitation; p  0.001). Such findings would
uggest that cardiac rehabilitation improves parasympathetic
unction, which may at least in part contribute to the
ecreased mortality seen among these patients.
Why abnormal HRR after exercise is associated with an
ncreased risk of death is not completely understood. One
ontributing factor could be that impaired HRR appears to
orrelate with the presence of underlying ischemic coronary
rtery disease. Georgoulias et al. (91) found that patients
ith impaired HRR (as defined by an HR decrease 21
eats/min 1 min after abrupt cessation of exercise) had a
igher myocardial perfusion score (indicating more isch-
mia) on nuclear stress testing compared with patients with
ormal HRR. Therefore, patients with impaired HRR may
e more likely to have underlying active ischemia, which
ould at least in part account for their higher mortality risk.
owever, ischemia does not appear to be the only factor
ontributing to their risk. In a prospective study of 2,935
atients who had both exercise testing and coronary angiog-
aphy, Vivekananthan et al. (92) found that impaired HRR
as predictive of mortality independent of the severity of
oronary artery disease seen on angiography. Given the
ubstantial role that parasympathetic activation plays in
arly recovery and the prognostic significance of diminished
arasympathetic tone at rest, it is tempting to infer that
arasympathetic “insufficiency” is implicated in the in-
reased mortality risk in patients with abnormal HRR.
owever, there are no data that directly implicate dimin-
shed parasympathetic tone as the underlying mechanism
ehind the increased risk of death in such patients.
Heart rate recovery after exercise is emerging as a new
nd important prognostic index. Further investigation into
he physiological basis and prognostic significance of auto-
omic function during recovery is warranted to better
elineate its relation to the risk for total mortality and
udden cardiac death.
hysiological Construct
iven the wealth of information available regarding the
hysiological and prognostic significance of HR, HRV, and
RR, it is important to synthesize this information into a
seful framework that can form the foundation for furthertudy. The following simplified model may be useful to
onceptualize autonomic control of HR and is shown
chematically in Figure 1. Although it is likely that auto-
omic control of the HR also reflects autonomic effects on
ardiac parameters other than the sinus node, it is important
o recognize that there is differential innervation within the
eart and that there may be differing effects in different
egions of the heart (93).
In its simplest formulation, HR is used to represent
ympathovagal balance. Although this term is poorly de-
ned, it is reasonable to use it as a measure of the net effects
f the sympathetic and parasympathetic inputs into the
inus node. This concept is captured by HR. The HRV is
hen used to quantify the modulation of the sympathetic
nd parasympathetic inputs. The HRR represents the re-
ponsiveness and/or activity of the parasympathetic nervous
Figure 1 Schematic Diagram Showing Physiological
Parasympathetic and Sympathetic Effects
This diagram shows the physiological parasympathetic and sympathetic effects
on the sinus node to increase or decrease, respectively, the R-R interval and
their interaction (“accentuated antagonism”). These inputs and their changes
with physiological activities (i.e., respiration, exercise) influence the R-R inter-
val, heart rate variability, and heart rate recovery. These characteristics can be
quantified through short-term electrocardiogram (ECG) recordings, Holter moni-
toring, or stress testing. The heart rate, heart rate variability, and heart rate
recovery that are measured through these tests provide prognostic information
in patients with cardiovascular disease. Figure illustration by Rob Flewell.
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May 6, 2008:1725–33 Assessment of Autonomic Functionystem to cessation of exercise. Other parameters of the
esponsiveness of the autonomic system, such as baroreflex
ensitivity and heart rate turbulence have also been shown to
rovide prognostic information. It should be noted that all
f these techniques rely upon normal sinus node function
nd adequate recording of sinus node activity. The presence
f sinus node dysfunction and significant atrial and/or
entricular ectopy in elderly patients with heart disease
ould make these measurements less useful.
Although it is likely that these indices and the related
hysiologies are dependent upon each other, they also each
ave distinct and independent physiological significance.
ssues for Further Study
lthough there are compelling data that parasympathetic
ctivity is associated with improved survival, the precise
echanism of parasympathetic protection is not clear. An
ttractive hypothesis is that parasympathetically induced
hanges in cardiac electrophysiology exert antiarrhythmic
ffects. It is well known that parasympathetic stimulation
ffects sinus nodal automaticity and AV nodal dromotropy
94,95). Several studies have also demonstrated changes in
entricular refractoriness with parasympathetic stimulation
r blockade (96,97); parasympathetic effects on ventricular
efractoriness may be antiarrhythmic. However, it is possi-
le that some of the benefits of parasympathetic tone are
ediated by other mechanisms, such as reduction in HR.
anoli et al. (2) studied the effects of vagal stimulation and
agal stimulation plus atrial pacing on the prevention of
xercise and ischemia-induced ventricular fibrillation in
ogs with a healed MI. Although vagal stimulation pre-
ented most episodes of ventricular fibrillation, when atrial
acing was instituted to prevent the HR reduction associ-
ted with vagal stimulation, approximately one-half of the
nimals had ventricular fibrillation. This suggests that the
enefits of vagal stimulation may be partially due to an
R-lowering effect and partially due to other parasympa-
hetic effects. It seems likely that most of these other
rotective effects of parasympathetic tone on sudden death
ould result from electrophysiological effects occurring in
he ventricle. Yet, HR, HRV, and HRR all measure
utonomic effects on the sinus node and may not provide
dequate assessment of parasympathetic effects in the ven-
ricle. Differential autonomic effects have been noted in
arious regions of the heart (93). Divergent changes in Q-T
nd R-R intervals (reflecting differential effects on ventric-
lar repolarization and heart rate) beyond that simply
xplained by rate dependence can be observed in healthy
ubjects (98). Cervical vagal stimulation does not change
RV and BRS after vagal denervation of the atria in dogs,
hereas changes in ventricular refractoriness are still in-
uced (44). These studies highlight the fact that autonomic
ffects on the sinus node are not necessarily predictive of
heir effects on the ventricles.The role of exercise and the associated changes in
utonomic function in the pathophysiology of sudden death
equire further exploration. The risk of cardiac arrest and
udden death is substantially increased during and immedi-
tely after vigorous activity (99,100). Experimental data
ave shown that animals susceptible to ventricular fibrilla-
ion have greater reductions in HRV (parasympathetic
odulation) during exercise compared with nonsusceptible
nimals (101). Interestingly, there was no significant differ-
nce between the 2 groups at rest. The HRR may provide
urther information regarding the risk for arrhythmias that
ccur in the setting of exercise or recovery.
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